Cervical Cancer by FIGO Stage 2018 — Trials

Cervical Cancer by FIGO Stage 2018 — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 33%
Top sponsor: Institut Paoli-Calmettes
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07305727	A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer(EPICOL-R)	recruiting	—	120	Centre Hospitalier Universitaire de NīmesOTHER	1	Jan 7, 2026	clinicaltrials
NCT05197881	Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix(ARTIA-Cervix)	recruiting	N/A	125	Varian, a Siemens Healthineers CompanyINDUSTRY